Related Experiment Videos

Mortality prediction models for pediatric intensive care: comparison of overall and subgroup specific performance

Idse H E Visser1, Jan A Hazelzet, Marcel J I J Albers

  • 1Department of Pediatrics, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands. i.visser@erasmusmc.nl

Intensive Care Medicine
|February 23, 2013
PubMed

Insights

The Paediatric Index of Mortality 2 (PIM2) and Pediatric Risk of Mortality 3 (PRISM3-24) models effectively predict mortality in pediatric intensive care units (PICUs), including neonates, but struggle with prolonged stays.

Area of Science:

  • Pediatric critical care medicine
  • Clinical epidemiology
  • Healthcare outcomes research

Background:

  • Accurate mortality prediction is crucial for resource allocation and clinical decision-making in pediatric intensive care units (PICUs).
  • Existing models like the Pediatric Index of Mortality (PIM) and Pediatric Risk of Mortality (PRISM) require validation in diverse patient populations and settings.

Purpose of the Study:

  • To validate the performance of PIM and PRISM model variants for mortality prediction in a Dutch PICU population.
  • To assess model performance across various subgroups, including neonates, different diagnoses, admission urgency, and length of stay (LoS).

Main Methods:

  • Comparative analysis of PIM and PRISM model variants using calibration and discrimination metrics (Area Under the Curve - AUC).
  • Evaluation of model performance in the overall cohort and predefined subgroups (diagnoses, age, urgency, LoS).
  • Data from 12,040 admissions of patients <16 years in 8 Dutch PICUs (2006-2009) were analyzed, excluding referred or rapidly deceased patients.

Main Results:

  • PIM2 variants demonstrated the best calibration. All models showed good discrimination (AUC > 0.83), including in neonates.
  • PRISM3-24 exhibited the highest discrimination overall (AUC 0.90) and in most subgroups (13/14).
  • Model performance, particularly discrimination (AUC < 0.73), declined for patients with LoS > 6 days.

Conclusions:

  • PIM2 and PRISM3-24 (after recalibration) are suitable for individualized mortality risk prediction in Western European PICUs.
  • Both models demonstrate good discrimination in most subgroups, including neonates.
  • Predictive accuracy is limited for patients with extended PICU stays (>6 days).
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...